LEO Pharma has launched a new treatment gel Xamiol® for scalp psoriasis. This gel formulation contains the proven combination of the Vitamin D analogue calcipotriol 50 microgram/g (as monohydrate) and the corticosteroid betamethasone 0.5 mg/g (as dipropionate). It is indicated for once-daily topical treatment of scalp psoriasis in adults and is recommended for four weeks and thereafter repeat treatment can be initiated under medical supervision. Xamiol®, an almost clear and odourless gel, differs from traditional scalp psoriasis treatments.